Merck & Co. Inc.’s sales in China grew by 58% to $275m in the 2019 first quarter, or by 67% excluding the negative impact from foreign exchange. That double-digit growth, led by newly launched products, prompted chairman and CEO Ken Frazier to highlight the beneficial effects of non-US markets on the company’s business.
“Our international business, which represented nearly 60% of our sales this quarter, has strong momentum, and we believe we have...








